Axsome Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September: Wells Fargo 21st Annual Healthcare Conference Fireside Chat: Wednesday, September 9, 2026, […]
\